381 |
DES for Left Main Intervention |
Marco Valgimigli |
Jul. 25. 08 |
380 |
Meta-Analysis of 3,900 Patients with Left Main Disease Intervention (BMS vs DES vs CABG) |
Duk-Woo Park |
Jul. 25. 08 |
379 |
Late Clinical Outcomes After DES |
Jeffrey J. Popma |
Jul. 18. 08 |
378 |
Endothelial Progenitor Cell Capture Technology and Beyond |
Michael Kutryk |
Jul. 18. 08 |
377 |
TAXUS 'On-Label' Clinical Outcomes & 'Off-Label' Experiences in Real World |
Keith D. Dawkins |
Jul. 18. 08 |
376 |
Clinical Experience with the Xience-V Stent |
Jacques J. Koolen |
Jul. 18. 08 |
375 |
The Endeavor Program: Update 2008 |
Mitchell W. Krucoff |
Jul. 18. 08 |
374 |
Overview of the Sirolimus Eluting Stent Program: A Spectrum of Safety and Efficacy Among Differing DES |
David E. Kandzari |
Jul. 18. 08 |
373 |
Recanalization of Chronic Carotid Artery Occlusion - Objective Improvement of Cerebral Perfusion |
Hsien-Li Kao |
Jul. 11. 08 |
372 |
Coronary Microvascular Resistance Estimated by A Novel Dual-Sensor (Pressure And Doppler Velocity) Guidewire Reflects Myocardial Viability After Myocardial Infarction |
Takashi Akasaka |
Jun. 13. 08 |